Immunization of Patients With Renal Cancer Using HLA-A2 and HLA-A3-Binding Peptides From Fibroblast Growth Factor 5 (FGF-5).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Renal cancer vaccine (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 01 Aug 2017 Biomarkers information updated
- 10 Oct 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 10 Oct 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.